| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |